STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and moreWorldPing
Image via STAT.

What happened

The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and PTSD…

Key facts

  • The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and PTSD…
  • Reported by STAT and published Tue, 06 Oct 2026 13:36:42 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

  2. What are hospital longevity programs, and what can they tell you about your health?

  3. STAT+: Are stem cell treatments about to have their day?

  4. STAT+: AstraZeneca opens new Boston site

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

STAT+: AstraZeneca opens new Boston siteWorldPing
STAT

STAT+: AstraZeneca opens new Boston site

AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.

Brief by WorldPing · Original reporting by STAT

'We were naive' about Hamas, Israeli ex-hostage Shoshan Haran saysWorldPing
France 24

'We were naive' about Hamas, Israeli ex-hostage Shoshan Haran says

In an interview with FRANCE 24, Israeli former hostage Shoshan Haran said "we were naive" about Hamas before the October 7, 2023 attack on her kibbutz. Held in Gaza for 50 days, she recalled refusing to "show weakness" to her captors.

Brief by WorldPing · Original reporting by France 24